| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5685423 | American Journal of Kidney Diseases | 2016 | 14 Pages |
Abstract
Our results agree with current recommendations for IV iron replacement for patients with CKD stage 5D and support increased use of IV iron for patients with CKD stages 3 to 5.
Keywords
erythropoiesis-stimulating agent (ESA)Ferumoxytoltransferrin saturation (TSAT)Quality of lifeIronOral ironferric carboxymaltoseSafetyChronic kidney disease (CKD)end-stage renal disease (ESRD)Blood transfusionIron dextranDialysisIron sucroseFerritinSystematic reviewIron supplementationhaemoglobinAnemiaFerric gluconate
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
Daniel MD, Benaya MD, Tomer MD, Uzi MD, PHD, Anat MD,